| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/03/2009 | WO2009144711A1 Compositions comprising red microalgae polysaccharides and metals |
| 12/03/2009 | WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | WO2009143715A1 Retinoid derivative and pharmaceutical composition and use thereof |
| 12/03/2009 | WO2009122045A3 Use of olive oil extract to control skin aging |
| 12/03/2009 | WO2009118191A3 Therapy for vitiligo |
| 12/03/2009 | WO2009114623A3 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 12/03/2009 | WO2009114087A3 A method for treating pruritus by administering fullerenes |
| 12/03/2009 | WO2009114084A3 Method for treating wounds by administering fullerenes |
| 12/03/2009 | WO2009103500A8 Means and methods for controlling commensales |
| 12/03/2009 | WO2009024677A3 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 12/03/2009 | WO2008073332A3 Creatine compositions for skin treatment |
| 12/03/2009 | US20090299268 Topical Aminolevulinic Acid-Photodynamic Therapy for the Treatment of Acne Vulgaris |
| 12/03/2009 | US20090298928 Composition and method for scalp and hair treatment |
| 12/03/2009 | US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/03/2009 | US20090298810 IL-8 Receptor Antagonists |
| 12/03/2009 | US20090298798 Combinations of adapalene and benzoyl peroxide for treating acne lesions |
| 12/03/2009 | US20090298783 Cosmetic Compositions |
| 12/03/2009 | US20090298759 C-Reactive Protein and Its Use to Treat Systemic Lupus Erythematosus and Related Conditions |
| 12/03/2009 | US20090297645 Fibroblast Activator and Method of Activating Fibroblast, Collagen Synthesis Promoter and Method of Promoting Collagen Synthesis, and Skin Antiaging Agent and Method of Preventing Aging of Skin |
| 12/03/2009 | US20090297634 Compositions for sustrained release of nitric oxide, methods of preparing same and uses thereof |
| 12/03/2009 | US20090297610 Composition and system to promote wound healing |
| 12/03/2009 | US20090297607 Biomimetic polymers and uses thereof |
| 12/03/2009 | US20090297586 Tissue Products Having A Cooling Sensation When Contacted With Skin |
| 12/03/2009 | DE202009012159U1 Salbe mit mehreren Schüssler-Salzen Ointment with several Schuessler salts |
| 12/03/2009 | DE20122900U1 Ubichinon Konzentrat Ubiquinone concentrate |
| 12/03/2009 | CA2725545A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | CA2725236A1 Compositions comprising red microalgae polysaccharides and metals |
| 12/03/2009 | CA2725111A1 Substituted carbinol compound having a cyclic linker |
| 12/03/2009 | CA2724639A1 Compositions comprising euphorbia prostrata and process of preparation thereof |
| 12/03/2009 | CA2720310A1 Compositions for prevention/prophylactic treatment of poison ivy dermatitis |
| 12/03/2009 | CA2719658A1 Compositions and methods for skin care |
| 12/02/2009 | EP2128265A1 Method for glycosylation of flavonoid |
| 12/02/2009 | EP2128248A1 Oligonucleotide compositions with enhanced efficiency |
| 12/02/2009 | EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 12/02/2009 | EP2127674A1 Hair regrowth promoter |
| 12/02/2009 | EP2127673A1 Pharmaceutical agent for prevention and treatment of skin disease induced by accelerated keratinization |
| 12/02/2009 | EP2127659A1 Use of high osmotic liquid composition in manufacturing medicament for enhancing wound healing |
| 12/02/2009 | EP2127540A1 Skin-beautifying agent |
| 12/02/2009 | EP2125787A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof |
| 12/02/2009 | EP2125775A1 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof |
| 12/02/2009 | EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 12/02/2009 | EP2125697A1 Positively charged water-soluble prodrugs of retinoids and retinoid-like compounds with very high skin penetration rates |
| 12/02/2009 | EP2125009A1 Medicinal formulation containing a combination of hiv type i and hiv type ii |
| 12/02/2009 | EP2124960A1 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases |
| 12/02/2009 | EP2124943A1 Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors |
| 12/02/2009 | EP2124934A2 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline |
| 12/02/2009 | EP2124932A2 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings |
| 12/02/2009 | EP2124928A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors |
| 12/02/2009 | EP2124924A1 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases |
| 12/02/2009 | EP2124877A2 Personal care composition comprising botanical extract of ficus benghalensis |
| 12/02/2009 | EP1503763B1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 12/02/2009 | EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents |
| 12/02/2009 | EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 12/02/2009 | CN101595063A System and process for producing a low-suspended solids solution and uses therefore |
| 12/02/2009 | CN101594909A IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 12/02/2009 | CN101594871A Pyrrolopyrimidine compounds and their uses |
| 12/02/2009 | CN101594860A Adam inhibitor |
| 12/02/2009 | CN101594859A Compositions comprising carnosic acid 12-methylether |
| 12/02/2009 | CN101591388A Soluble tumor necrosis factor (TNF) receptor mutant |
| 12/02/2009 | CN101591368A Girald pteroxygonum root neoflavonoid compound |
| 12/02/2009 | CN101590223A SOD complex capsule and preparation method thereof |
| 12/02/2009 | CN101590222A SOD cell repair liquid and preparation method thereof |
| 12/02/2009 | CN101590211A Pure Chinese medicinal oral preparation for treating psoriasis and preparation method thereof |
| 12/02/2009 | CN101590197A Pure Chinese medicinal whitening anti-freckle agent and preparation method thereof |
| 12/02/2009 | CN101590153A Compound skin comfort liquid |
| 12/02/2009 | CN101590142A Chinese medicinal composition for treating acne rosacea and preparation method thereof |
| 12/02/2009 | CN101590134A Total triterpene of garden burnet root with anti-inflammatory and analgesic effects and preparation method thereof |
| 12/02/2009 | CN101590133A Manufacture method of powder for treating burns and scalds |
| 12/02/2009 | CN101590132A Whelk-removing liniment and preparation method thereof |
| 12/02/2009 | CN101590125A Medicament for treating empyrosis and using method thereof |
| 12/02/2009 | CN101590110A Method for extracting bioflavonoid from mulberry |
| 12/02/2009 | CN101590098A Medicine for treating scalds and burns |
| 12/02/2009 | CN101590087A Composition for delaying female aging and preparation method thereof |
| 12/02/2009 | CN101590085A Body odor-removing powder |
| 12/02/2009 | CN101590077A Compound erythromycin zinc acetate ointment for local use |
| 12/02/2009 | CN101589803A Chinese angelica and pearl powder product with beauty and health care functions |
| 12/02/2009 | CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof |
| 12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 12/02/2009 | CN100563713C External preparation for skin |
| 12/02/2009 | CN100563683C Externally applied formulation for treating skin amyloidosis |
| 12/02/2009 | CN100563676C External use traditional Chinese medicine tincture for treating psoriasis |
| 12/02/2009 | CN100563672C Medicine for treating foot diseases and insole containing the said medicine |
| 12/02/2009 | CN100563663C Externally used antifungal drug for treating skin fester infection |
| 12/01/2009 | US7626044 Plant extracts comprising highly bioactive triptolide derivatives with low toxicity;(5-R)-5-hydroxytriptonide, (5R)-5-hydroxytriptolide, (5R)-5-hydroxy-14-epitriptolide. Delta 5,6-dehydrotriptonide, Delta 5,6-dehydrotriptolide; antiinflammatory agents; immunosuppressants; drug design |
| 12/01/2009 | US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 12/01/2009 | US7625934 Metalloproteinase inhibitors |
| 12/01/2009 | US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 12/01/2009 | US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/01/2009 | US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/01/2009 | US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections |
| 12/01/2009 | US7625860 Administering a combination of a cytotoxic agent and a fibroblastic growth factor antagonist, wherein the FGF antagonist enhances the efficacy of the cytotoxic agent |
| 12/01/2009 | US7625583 Microbiocidal fatty acids such as palmitoleic acid and lauric acid |
| 12/01/2009 | US7625562 Generation of cartilage using magnetizable particles |
| 12/01/2009 | CA2492196C Sulfotransferase inhibitors |
| 12/01/2009 | CA2461100C 4-imidazolin-2-one compounds |
| 12/01/2009 | CA2432121C Nitric oxide synthase inhibitor phosphate salt |
| 12/01/2009 | CA2208503C Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |